3SBio Inc (SSRX)

[surf1944]

3SBio Inc. Announces Filing of Annual Report on Form 20-F
Tuesday July 1, 8:30 am ET

SHENYANG, China, July 1 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX - News), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has filed with the SEC an annual report on Form 20-F for the year ended December 31, 2007. Copies of the report are available for download under the Investors page on the Company's website at http://bbs.3sbio.com/en/News/ShowInfo_n16.aspx?ID=30 .

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China.

For more information, please visit 3SBio on the web at: http://www.3sbio.com .

For more information, please contact:

Investor Contact:
Kevin Teo, CFO
3SBio Inc.
Tel: [phone]

Investor Relations (US):
Mahmoud Siddig
Taylor Rafferty
Tel: [phone]

Investor Relations (HK):
Ruby Yim
Taylor Rafferty
Tel: [phone]

Media Contact:
Jason Marshall
Taylor Rafferty
Tel: [phone]

http://biz.yahoo.com/prnews/080701/cntu015.html?.v=51